STOCKS TO BUY: We have identified several stocks that can potentially TRIPLE. Learn more!

Monday's Analysts' Upgrades and Downgrades

Todco (THE) upgraded at Morgan Stanley: THE was upgraded to Overweight, Morgan Stanley said. $50 price target. Estimates also upped, as jack-up rates should soon recover in the Gulf of Mexico.

STOCK COMMENTS / EPS CHANGES

Agilent (A) estimates lowered at Goldman: Goldman said it is reducing its 2007 estimates on A by 20 cents to $1.85 to account for Verigy distribution. Semiconductor test business distributed as special dividend to shareholders. Maintain Neutral rating and $35 target.

Bristol-Myers (BMY) estimates cut at Morgan Stanley: BMY estimates lowered through 2007, Morgan Stanley said. Company meeting did not improve outlook for Plavix. Equal-weight rating and $25 price target.

Luminent (LUM) outlook lowered at UBS: UBS said it is reduced its 2006 EPS estimates on LUM to $1.07 from $1.90 to reflect lower origination. Lowered target price to $11.50 from $12.

SiRF (SIRF) estimates raised at Piper: Piper said it is raising its 2007 estimates on SIRF by 4 cents to $1.10 a share based on growing comfort with company's longer-term growth opportunities. Maintained Outperform rating.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
TRY IT FREE
New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,297.50 -20.73 -0.14%
NASDAQ 3,482.18 30.05 0.87%
S&P 500 1,651.81 12.77 0.78%
US 10 Yr 2.173% -0.009

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs